RIL
GLUE icon

Rothschild Investment LLC’s Monte Rosa Therapeutics GLUE Stock Holding History

Rothschild Investment LLC’s Portfolio GLUE Stock Details GLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.54K Buy
105
+14
+15% +$265 ﹤0.01% 2649
2026
Q1 		$1.5K Sell
91
-9
-9% -$172 ﹤0.01% 2684
2025
Q4 		$1.57K Buy
100
+50
+100% +$674 ﹤0.01% 2491
2025
Q3 		$371 Sell
50
-55
-52% -$291 ﹤0.01% 2890
2025
Q2 		$474 Buy
105
+55
+110% +$245 ﹤0.01% 2763
2025
Q1 		$232 Sell
50
-70
-58% -$429 ﹤0.01% 2818
2024
Q4 		$833 Buy
+120
New +$900 ﹤0.01% 2317

Other funds holding GLUE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Rothschild Investment LLC's GLUE Position: Q2 2026 in Review

Rothschild Investment LLC increased its Monte Rosa Therapeutics (GLUE) stake by 15% in Q2 2026, buying an estimated $265 and bringing the position to 105 shares worth $2.54K. The position accounts for ﹤0.01% of the portfolio, ranked #2649.

Rothschild Investment LLC first reported a position in GLUE in Q4 2024 and has held it in 7 quarters since. 52 funds tracked by Wall St. Rank hold GLUE as of Q2 2026.

  • Rothschild Investment LLC held 105 shares of Monte Rosa Therapeutics worth $2.54K as of Q2 2026.
  • Rothschild Investment LLC bought 14 Monte Rosa Therapeutics shares in Q2 2026, an estimated $265.
  • Monte Rosa Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2649 holding.
  • Rothschild Investment LLC first reported a position in Monte Rosa Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 52 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.